Recommended Mix Momentum Stocks: Keysight Technologies (NYSE:KEYS), The PNC Financial Services Group (NYSE:PNC)

Keysight Technologies, Inc. (NYSE:KEYS) [Trend Analysis] plunged reacts as active mover, shares a loss -0.92% to traded at $36.65 and the percentage gap between open changing to regular change was -0.57%. Keysight Technologies Inc. (KEYS) has agreed to acquire Ixia (XXIA) in an all-cash transaction totaling approximately $1.6 billion in consideration, net of cash, the two companies said.

Under the terms of the deal, Ixia shareholders will receive $19.65 per share in cash. This represents a premium of about 45 percent to Ixia’s unaffected closing stock price on December 1, 2016, the last trading day prior to media reports that Ixia was considering strategic alternatives.The board of directors of both companies have unanimously authorized the transaction, which is anticipated to close no later than the end of October 2017. The transaction is subject to approval by Ixia shareholders. The firm’s current ratio calculated as 2.90 for the most recent quarter. The firm past twelve months price to sales ratio was 2.17 and price to cash ratio remained 8.10. As far as the returns are concern, the return on equity was recorded as 22.40% and return on investment was 14.40% while its return on asset stayed at 9.20%. The firm has total debt to equity ratio measured as 0.73.

The PNC Financial Services Group, Inc. (NYSE:PNC) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 0.29% to $120.72. PNC Financial Services Group Inc. (PNC) will increase its stock buyback plan by $300 million on top of the $2 billion it had already reported previously, the company said Monday. The stock repurchase program is slated to expire on June 30. The share price of PNC attracts active investors, as stock price of week volatility recorded 1.33%. The stock is going forward to its 52-week low with 59.09% and lagging behind from its 52-week high price with -1.06%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *